• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Ranitidine Hydrochloride (Zantac) Injection

 Status: Currently in Shortage

 » Date first reported: 07/31/2014
 » Therapeutic Categories: Gastroenterology; Pediatric

Covis Injectables (New 07/31/2014)

Company Contact Information:
866-488-4423

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Zantac (ranitidine hydrochloride) INJECTION, SOLUTION | 25 mg/mL (50mg vial (10s)) (NDC 24987-362-10) Estimated recovery: September 2014 Shortage per Manufacturer: Supplier interruption due to API Shortage of an active ingredient.
Zantac (ranitidine hydrochloride) INJECTION, SOLUTION | 25 mg/mL (150mg vial (1s))(NDC 24987-363-10) Estimated recovery: September 2014 Shortage per Manufacturer: Supplier interruption due to API Shortage of an active ingredient.
Zantac (ranitidine hydrochloride) INJECTION, SOLUTION | 25 mg/mL (1000mg vial (1s))(NDC 24987-364-10) Estimated recovery: September 2014 Shortage per Manufacturer: Supplier interruption due to API Shortage of an active ingredient.

Zydus Pharms USA (New 08/08/2014)

Company Contact Information:
609-730-1900

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Ranitidine Hydrochloride Injection USP, 25mg/mL, 6 mL (NDC 68382-423-06) Available Although demand increased, Zydus will be able to ship this product. Demand increase for the drug.
Ranitidine Hydrochloride Injection USP, 25mg/mL, 2mL (NDC 68382-422-02) Available Although demand increased, Zydus will be able to ship this product. Demand increase for the drug.
-
-